Tom Bowen

4.0k total citations
37 papers, 1.4k citations indexed

About

Tom Bowen is a scholar working on Genetics, Hematology and Epidemiology. According to data from OpenAlex, Tom Bowen has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 11 papers in Hematology and 5 papers in Epidemiology. Recurrent topics in Tom Bowen's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (10 papers), Allergic Rhinitis and Sensitization (5 papers) and Vitamin K Research Studies (5 papers). Tom Bowen is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (10 papers), Allergic Rhinitis and Sensitization (5 papers) and Vitamin K Research Studies (5 papers). Tom Bowen collaborates with scholars based in Canada, United States and Germany. Tom Bowen's co-authors include Henriette Farkas, Konrad Bork, Lilian Varga, Anete Sevciovic Grumach, Timothy Craig, Hilary Longhurst, Bruce Ritchie, S Cassol, Alexander Nast and Inmaculada Martinez‐Saguer and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Tom Bowen

37 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Bowen Canada 17 910 352 328 298 259 37 1.4k
WE Fibbe Netherlands 24 302 0.3× 823 2.3× 81 0.2× 319 1.1× 44 0.2× 36 1.9k
Kanjaksha Ghosh India 17 297 0.3× 386 1.1× 71 0.2× 31 0.1× 36 0.1× 93 1.0k
Renée M. Ned United States 18 186 0.2× 297 0.8× 42 0.1× 63 0.2× 175 0.7× 31 1.3k
Deborah Hurst United States 17 788 0.9× 1.0k 3.0× 50 0.2× 148 0.5× 37 0.1× 32 1.8k
George H. Goldsmith United States 15 194 0.2× 271 0.8× 81 0.2× 24 0.1× 71 0.3× 35 723
Inmaculada de la Torre Spain 25 332 0.4× 575 1.6× 1.4k 4.3× 184 0.6× 8 0.0× 93 2.4k
Swati Goel United States 13 264 0.3× 339 1.0× 79 0.2× 127 0.4× 16 0.1× 63 1.1k
Anna Gayà Spain 21 506 0.6× 655 1.9× 87 0.3× 210 0.7× 12 0.0× 51 2.1k
Alfred Ian Lee United States 18 279 0.3× 269 0.8× 47 0.1× 367 1.2× 26 0.1× 100 2.0k
Wylie Burke United States 11 196 0.2× 222 0.6× 26 0.1× 324 1.1× 179 0.7× 15 1.2k

Countries citing papers authored by Tom Bowen

Since Specialization
Citations

This map shows the geographic impact of Tom Bowen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Bowen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Bowen more than expected).

Fields of papers citing papers by Tom Bowen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Bowen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Bowen. The network helps show where Tom Bowen may publish in the future.

Co-authorship network of co-authors of Tom Bowen

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Bowen. A scholar is included among the top collaborators of Tom Bowen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Bowen. Tom Bowen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Konerding, Uwe, Tom Bowen, Sylvia Elkhuizen, et al.. (2020). The impact of accessibility and service quality on the frequency of patient visits to the primary diabetes care provider: results from a cross-sectional survey performed in six European countries. BMC Health Services Research. 20(1). 800–800. 4 indexed citations
2.
3.
Konerding, Uwe, Tom Bowen, Sylvia Elkhuizen, et al.. (2017). The impact of travel distance, travel time and waiting time on health-related quality of life of diabetes patients: An investigation in six European countries. Diabetes Research and Clinical Practice. 126. 16–24. 11 indexed citations
4.
Craig, Timothy, Konrad Bork, Tom Bowen, et al.. (2012). WAO Guideline for the Management of Hereditary Angioedema. SHILAP Revista de lepidopterología. 5(12). 182–199. 242 indexed citations
5.
Khan, Faisal, Bazir Serushago, Tom Bowen, et al.. (2012). Basophil activation test compared to skin prick test and fluorescence enzyme immunoassay for aeroallergen-specific Immunoglobulin-E. Allergy Asthma and Clinical Immunology. 8(1). 1–1. 25 indexed citations
6.
7.
Khan, Faisal, Bazir Serushago, Tom Bowen, et al.. (2011). Allergen-specific T cell quantity in blood is higher in allergic compared to nonallergic individuals. Allergy Asthma and Clinical Immunology. 7(1). 6–6. 3 indexed citations
8.
Bowen, Tom, et al.. (2010). Management of hereditary angioedema: 2010 Canadian approach. Allergy Asthma and Clinical Immunology. 6(1). 20–20. 9 indexed citations
9.
Bowen, Tom. (2010). Hereditary Angioedema Consensus 2010. Allergy Asthma and Clinical Immunology. 6(1). 13–13. 8 indexed citations
10.
Shehata, Nadine, Valerie A. Palda, Tom Bowen, et al.. (2009). The Use of Immunoglobulin Therapy for Patients With Primary Immune Deficiency: An Evidence-Based Practice Guideline. Transfusion Medicine Reviews. 24. S28–S50. 82 indexed citations
11.
Shehata, Nadine, Heather Hume, Valerie A. Palda, et al.. (2008). Immune Globulin for Patients with Primary Immune Deficiency: An Evidence Based Practice Guideline. Blood. 112(11). 4705–4705. 1 indexed citations
12.
Leith, Eric, Tom Bowen, David W. Fischer, et al.. (2006). Consensus Guidelines on Practical Issues of Immunotherapy-Canadian Society of Allergy and Clinical Immunology (CSACI). Allergy Asthma and Clinical Immunology. 2(2). 47–61. 17 indexed citations
13.
Bowen, Tom, Jacques Hébert, Gordon L. Sussman, et al.. (2004). Canadian trial of sublingual swallow immunotherapy for ragweed rhinoconjunctivitis. Annals of Allergy Asthma & Immunology. 93(5). 425–430. 52 indexed citations
14.
Bowen, Tom, Jacques Hébert, Bruce Ritchie, et al.. (2003). Management of hereditary angioedema: a Canadian approach. Transfusion and Apheresis Science. 29(3). 205–214. 12 indexed citations
15.
Townsend, G. E., et al.. (1996). Enoxaparin for Unstable Angina and Ancrod for Cardiac Surgery following Heparin Allergy. Annals of Pharmacotherapy. 30(5). 476–480. 14 indexed citations
16.
Mahoney, Donald H., Douglas Strother, BM Camitta, et al.. (1996). High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric oncology group study.. Journal of Clinical Oncology. 14(2). 382–388. 81 indexed citations
17.
Krivit, William, Martin R. Klemperer, M J Cowan, et al.. (1995). Survival in Hurler's disease following bone marrow transplantation in 84 patients. Bone Marrow Transplantation. 15(1). 14 indexed citations
18.
Cassol, S, R Pal, Matthew J. Naylor, et al.. (1989). Primer-mediated enzymatic amplification of cytomegalovirus (CMV) DNA. Application to the early diagnosis of CMV infection in marrow transplant recipients.. Journal of Clinical Investigation. 83(4). 1109–1115. 88 indexed citations
19.
Huchcroft, Shirley A., et al.. (1985). Compliance with postpartum Rh isoimmunization prophylaxis in Alberta.. PubMed. 133(9). 871–5. 8 indexed citations
20.
Bowen, Tom, et al.. (1974). Revolt to revolution : studies in the 19th and 20th century European experience. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by WE Fibbe Breakdown of academic impact, for papers by Kanjaksha Ghosh Breakdown of academic impact, for papers by Renée M. Ned Breakdown of academic impact, for papers by Deborah Hurst Breakdown of academic impact, for papers by George H. Goldsmith Breakdown of academic impact, for papers by Inmaculada de la Torre Breakdown of academic impact, for papers by Swati Goel Breakdown of academic impact, for papers by Anna Gayà Breakdown of academic impact, for papers by Alfred Ian Lee Breakdown of academic impact, for papers by Wylie Burke
Rankless by CCL
2026